These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 5736035)

  • 21. Study of liver functions in cases of diabetes mellitus receiving sulphonylureas.
    Dube BK; Kumar A
    Indian Pract; 1966 Oct; 19(10):679-87. PubMed ID: 5923489
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of hypoglycemic agents on blood lipids and body weight in ketoacidosis-resistant diabetics.
    Gershberg H; Javier Z; Hulse M; Hecht A
    Ann N Y Acad Sci; 1968 Mar; 148(3):914-24. PubMed ID: 4968572
    [No Abstract]   [Full Text] [Related]  

  • 23. [Plasma lipids in patients with diabetes mellitus].
    Braunsteiner H; Sailer S; Sandhofer F
    Klin Wochenschr; 1966 Feb; 44(3):116-9. PubMed ID: 4861036
    [No Abstract]   [Full Text] [Related]  

  • 24. [The influence of tolbutamide on diabetic fatty liver].
    Beringer A; Hrabal I; Irsigler K; Thaler H
    Dtsch Med Wochenschr; 1967 Dec; 92(52):2388-92. PubMed ID: 4864250
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of oral antidiabetics on the unesterified fatty acid content of rat plasma].
    Puls W; Kroneberg G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):53-4. PubMed ID: 4231866
    [No Abstract]   [Full Text] [Related]  

  • 26. Correlation between serum concentration and hypoglycemic effect of chlorpropamide in man.
    Jankowski A; Wichliński LM; Bokowski W; Romański B
    Pol J Pharmacol Pharm; 1984; 36(5):449-53. PubMed ID: 6533629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose tolerance in diabetes mellitus during treatment with the sulfonylurea hypoglycemic agents.
    Herman JB
    Isr J Med Sci; 1966; 2(6):733-7. PubMed ID: 5956689
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rapid changes in blood lipid parameters induced by glucuronyl glucosamine glycan sulfate in obese diabetic and hyperlipidemia patients].
    Ferlito S; La Spina E; Fichera C; Cultrera E; Patanè M; Ciulla P
    Arch Sci Med (Torino); 1982; 139(4):441-8. PubMed ID: 7168636
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of physical exercise on the glyco-lipid effect in normal and diabetic subjects].
    Ferlito S; Di Mauro C; Costa A; Branca S; Raudino M
    G Clin Med; 1980 Oct; 61(10):728-39. PubMed ID: 7016646
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
    Frier BM; Ashby JP; Nairn IM; Baird JD
    Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R; Wendorff HJ; Field JB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
    [No Abstract]   [Full Text] [Related]  

  • 32. [On disorders of blood lipid fractions (dyslipemia) in chemical diabetes mellitus (epidemiological study)].
    Mincu I; Câmpeanu S; Dumitrescu C; Mihalache N
    Med Interna (Bucur); 1973 Mar; 25(3):307-23. PubMed ID: 4793932
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of glibenclamide on non-esterified fatty acid levels in the plasma of the severely alloxan diabetic rat.
    Foy JM; Standing VF
    Experientia; 1973 Aug; 29(8):1006-8. PubMed ID: 4200262
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of anti-diabetic therapy on certain serum lipid fractions.
    Kumar D; Gupta NN; Mehrotra RM
    J Assoc Physicians India; 1967 Dec; 15(12):555-61. PubMed ID: 5587366
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of the tolbutamide test on plasmatic concentration of NEFA in the climacteric].
    Quinto P; Orlandi C
    Minerva Ginecol; 1968 Apr; 20(8):678-87. PubMed ID: 5738756
    [No Abstract]   [Full Text] [Related]  

  • 36. Fibrinolytic activity in diabetics before and after chlorpropamide therapy.
    Mehrotra TN; Mital HS; Mishra SD; Singh VS; Kumar M
    J Assoc Physicians India; 1978 May; 26(5):375-8. PubMed ID: 730717
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of diabetes mellitus on drug metabolism in man.
    Daintith H; Stevenson IH; O'Malley K
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):55-8. PubMed ID: 1248919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigations on the antilipolytic activity of sulfonylureas in man with indications on limit dosages concerning their insulin-secreting properties.
    Rosak C; Haupt E; Beyer J; Schöffling K
    Horm Metab Res; 1974 Nov; 6(6):464-70. PubMed ID: 4217757
    [No Abstract]   [Full Text] [Related]  

  • 39. Variability in blood cholesterol, triglycerides, free fatty acids, glucose and body weight in maturity-onset diabetics.
    Hulse M; Gershberg H
    Am J Med Sci; 1969 Aug; 258(2):114-20. PubMed ID: 5805233
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of diabetes mellitus with metformin].
    Parrow A
    Lakartidningen; 1968 Nov; 65(47):4671-6 passim. PubMed ID: 5742151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.